Christopher D. Maggiore - Jul 28, 2022 Form 4/A - Amendment Insider Report for Zivo Bioscience, Inc. (ZIVO)

Role
Director, 10%+ Owner
Signature
/s/ Christopher D. Maggiore
Stock symbol
ZIVO
Transactions as of
Jul 28, 2022
Transactions value $
$0
Form type
4/A - Amendment
Date filed
12/8/2022, 03:17 PM
Date Of Original Report
Aug 1, 2022
Previous filing
Feb 16, 2022
Next filing
Aug 1, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZIVO Nonstatutory Stock Option to Purchase Common Stock Award $0 +15.8K $0.00 15.8K Jul 28, 2022 Common stock 15.8K $3.61 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment is being filed solely to correct the date of the transaction reported to July 28, 2022.
F2 The option was issued pursuant to the 2021 Equity Incentive Plan and vests as follows: 25% on the first three 3-month anniversaries of the grant, and 25% on the day prior to the Company's 2023 Annual Meeting of Stockholders, subject to the reporting person's continuous service on each applicable vesting date.